GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2007 (Vol. 27, No. 6)

FUGOID

URL:web.austin.utexas.edu/fugoid/introndata/main.htm
  • Useful information
  • Difficult access to info
The name of this site caught my eye first. Sounding like the name of a cheap science fiction monster, FUGOID is actually an acronym for Function Genomics of Organellar Introns Database. Jeez—reality is almost always more boring than one’s imagination. That’s not to say, however, that the site is not useful. Indeed, introns in organelle genomes are of considerable interest for their ability to self splice. Add to that their ability to act as mobile genetic elements, and you have a lively set of jumping genes. The database allows users numerous search options, including by reference and by intron information. The latter includes over 15 specifiable criteria, including gene name, sequence, size, genome, mitochondria/chloroplast, and more. With so many options, I expected a truly enormous database, but in reality, there appeared to be just over 400 entries. Worse, access to the info was kind of clunky—one has to follow specific instructions for entering text into the search boxes. This number of entries could easily be presented in a list and this option should be considered by the site’s designers.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?